Tacrolimus treatment markedly reduced IL-21– and IFN-γ–producing Tph cells in the salivary glands, revealing that these SjS-like symptoms are caused by activated Tph cells (Figure 5F). This evidence concerns the gene TPH1 and Schwartz-Jampel syndrome.